BRIEF published on 03/27/2025 at 09:36, 14 days 16 hours ago Grünenthal Reports Strong 2024 Financial Results Financial Results Strategic Growth US Market Expansion Grünenthal 2024 Valinor Acquisition
PRESS RELEASE published on 03/27/2025 at 09:31, 14 days 16 hours ago Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal reports exceptional 2024 financial results driven by strategic growth and Valinor acquisition in the US Financial Results 2024 Strategic Growth Grünenthal Valinor Acquisition
BRIEF published on 12/06/2024 at 13:22, 4 months 4 days ago Grünenthal Successfully Issues €500 Million Bond Bond Issuance Grünenthal Maturity Profile €500 Million Finance Strategy
PRESS RELEASE published on 12/06/2024 at 13:17, 4 months 4 days ago Grünenthal successfully places new €500 million bond Grünenthal GmbH successfully places new €500 million bond to strengthen capital structure and pursue growth strategy, enhancing flexibility for investments and innovation Growth Strategy Bond Capital Structure Debt Issue Grünenthal GmbH
BRIEF published on 11/27/2024 at 09:40, 4 months 13 days ago Grünenthal Announces €500 Million Bond Pricing Bond Issuance Credit Ratings Debt Refinancing €500 Million Grünenthal GmbH
PRESS RELEASE published on 11/27/2024 at 09:35, 4 months 13 days ago Grünenthal announces pricing of €500 million bond Grünenthal GmbH announces pricing of €500 million bond to enhance capital structure and maturity profile. New financing to refinance existing debt and repurchase outstanding notes Bond Finance Debt Pricing Grünenthal GmbH
BRIEF published on 03/25/2024 at 09:35, 1 year ago Grünenthal Announces Strong Financial Results for 2023 with Continued Focus on R&D and Strategic Acquisitions Pharmaceuticals Annual Results Strategic Acquisitions Grünenthal R&D Investment
PRESS RELEASE published on 03/25/2024 at 09:30, 1 year ago Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Acquisitions 2023 Results Record Revenue R&D Investments Grünenthal
PRESS RELEASE published on 04/25/2023 at 12:51, 1 year 11 months ago Grünenthal GmbH: Grünenthal successfully places new €300 million bond
PRESS RELEASE published on 04/19/2023 at 07:55, 1 year 11 months ago Grünenthal GmbH: Grünenthal announces pricing of €300 million bond
Published on 04/11/2025 at 00:00, 1 hour 58 minutes ago Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
Published on 04/10/2025 at 23:00, 2 hours 58 minutes ago Highlander Silver Receives Conditional Approval to List on the TSX, Files Base Shelf Prospectus and Establishes ATM Program as Longer Term Financial Alternatives
Published on 04/10/2025 at 22:15, 3 hours 43 minutes ago Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Published on 04/10/2025 at 22:15, 3 hours 43 minutes ago SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special Dividend
Published on 04/10/2025 at 20:47, 5 hours 10 minutes ago EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4
Published on 04/10/2025 at 20:44, 5 hours 13 minutes ago EQS-Adhoc: artnet AG: artnet is in talks with two investors regarding a potential takeover offer
Published on 04/10/2025 at 19:00, 6 hours 58 minutes ago Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 7 hours ago EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 17:45, 8 hours 13 minutes ago EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/09/2025 at 18:59, 1 day 6 hours ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 7 hours ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 8 hours ago COGELEC : 2024 full-year results and Q1 2025 revenue.
